Hair loss · Women
Female pattern hair loss:
diagnosis first, then the right treatment.
In women, pattern hair loss usually shows as widening of the parting and thinning over the top of the head, with the front hairline kept. Because thyroid disease, iron deficiency, hormonal conditions and stress-related shedding can look similar, a proper diagnosis comes before any treatment, surgical or not.
Quick answer
What is the best treatment for female pattern hair loss?
Topical minoxidil has the best evidence. A Cochrane review of 47 trials found that women using minoxidil were almost twice as likely as those on placebo to see moderate-to-marked regrowth (RR 1.93), with 2% and 5% performing similarly. Oral spironolactone is used off-label, supported mostly by observational studies. A hair transplant suits only some women: those with a defined thinning area and a stable, dense donor area — not diffuse thinning all over.
6.0%
Chinese women with pattern loss
Community study, six cities, 15,257 people
Wang et al., Br J Dermatol 2010
RR 1.93
Moderate-to-marked regrowth on minoxidil
157/593 vs 77/555 on placebo; moderate-quality evidence
Cochrane review 2016
+9.1 hairs/cm²
5% foam once daily vs vehicle
404 women, 24 weeks
Bergfeld et al., J Drugs Dermatol 2016
15.3%
Surgical patients who are women
ISHRS members, 2024 data
ISHRS Practice Census 2025
30.0%
Female procedures done by strip (FUT)
vs 12.5% in men; FUE 68.2%
ISHRS Practice Census 2025
The pathway
Four steps, in order.
Diagnosis
Scalp examination and trichoscopy, plus blood tests your dermatologist chooses (for example, thyroid and iron). Rules out shedding conditions and scarring alopecias.
Dermatology
Topical minoxidil
The best-studied treatment for women. Results take months; stopping loses the gain. Unwanted facial hair is possible.
Daily
Specialist medicines
Oral spironolactone or low-dose oral minoxidil, chosen by a dermatologist. Not for pregnancy. Finasteride 1 mg was no better than placebo in women.
Prescription
Hair transplant
For a defined area of thinning (often the parting or a high hairline) with a stable, dense donor area. Strip harvesting is common because the donor area need not be shaved.
After assessment
The evidence
What has been tested in women
The 2016 Cochrane review pooled 47 trials with 5,290 participants. Its clearest finding concerned minoxidil. Most other treatments rest on small or low-quality studies.
| Treatment | Evidence | Notes |
|---|---|---|
| Topical minoxidil (2% or 5%) | RR 1.93 for moderate-to-marked regrowth vs placebo; +13.2 hairs/cm² (low quality) | No difference shown between 2% and 5% in women |
| 5% minoxidil foam, once daily | +10.9 hairs/cm² at week 12, +9.1 at week 24 vs vehicle (404 women) | Low rates of irritation and facial hair, similar to vehicle |
| Oral spironolactone | 56.6% overall improvement in a review mixing RCTs and observational studies | Off-label; menstrual changes 11.9%; not in pregnancy |
| Finasteride 1 mg | No better than placebo (RR 0.95, low quality) | Not indicated for women (US label) |
| Low-level laser | More terminal hairs than sham at 26 weeks (trial included 141 women) | FDA 510(k)-cleared devices |
| Hair transplant | Used in selected women; 15.3% of surgical patients in 2024 | Not for diffuse thinning |
Sources: van Zuuren (Cochrane) 2016; Bergfeld 2016; Aleissa 2023; Jimenez 2014; ISHRS 2025.
Surgery
When a transplant suits women
Many women with pattern loss have thinning that extends into the donor area too. In that case, moved grafts may not last, and surgery can trigger shedding of the surrounding hair. A transplant works best for a defined, stable area: a widened parting, a high or reshaped hairline, or a scar. The donor area at the back should stay dense.
Strip harvesting (FUT) was used in 30% of female procedures in the 2025 ISHRS census, compared with 12.5% in men. That's mainly because women often prefer not to shave the donor area. Medication is usually continued afterwards to protect the native hair.
Hair clinics
Where women's hair loss
is diagnosed and treated.
Plastic Surgery Hospital, CAMS 中国医学科学院整形外科医院
National specialist plastic surgery hospital with a dedicated hair transplant centre (毛发移植中心)
Shanghai Ninth People's Hospital 上海交通大学医学院附属第九人民医院
Plastic & reconstructive surgery department lists hair transplantation; international department opened January 2024
Huashan Hospital, Fudan University — Dermatology 复旦大学附属华山医院皮肤科
Hair-loss medicine; international department (Huashan Worldwide Medical Center) since 1989
Peking Union Medical College Hospital — Dermatology 北京协和医院皮肤科
Hair-disorder clinic opened January 2026 — diagnosis and medical treatment, not surgery
FAQ
Women's hair loss — answered.
- How do I know it's female pattern hair loss?
- Typical signs are a widening parting and thinning over the top of the head with the front hairline kept, often graded on the Ludwig scale. But thyroid problems, low iron, hormonal conditions, recent illness or stress-related shedding (telogen effluvium) can look similar. A dermatologist examines the scalp and decides which tests you need.
- Should I use 2% or 5% minoxidil?
- In the Cochrane review, 2% and 5% performed similarly in women. Once-daily 5% foam was effective in a 404-woman trial and may be easier to use. Your dermatologist can advise.
- Is spironolactone effective for hair loss?
- It's used off-label and is often combined with minoxidil. A 2023 systematic review reported improvement in 56.6% of women overall (65.8% with combination therapy), but most of the studies were observational and the results varied widely. It must not be used in pregnancy.
- Can women have a hair transplant?
- Yes, selected women can. Women made up 15.3% of surgical patients in the 2025 ISHRS census. It suits a defined, stable area of thinning with a good donor area, not diffuse thinning across the whole scalp.
- Will hair loss treatments affect pregnancy?
- Some can. Spironolactone and finasteride should not be used in pregnancy, and pregnant women shouldn't handle crushed finasteride tablets. Tell your doctor if you are pregnant, breastfeeding or planning a pregnancy.
Related guides
Hair transplant in China (hub)
Who it suits, how it's regulated, hospitals and the whole timeline.
Read the guideFUE vs FUT
Two ways to harvest grafts: scars, yield and who suits which.
Read the guideAm I a candidate?
Norwood stages, donor area, age, and when surgery is the wrong answer.
Read the guideRecovery timeline
Day 1 to month 18: washing, shedding, regrowth and the final result.
Read the guideFinasteride, minoxidil & PRP
What the trials show, side effects, and why it matters with a transplant.
Read the guideHair transplant tours
Beijing and Shanghai routes at public hospitals, with recovery-friendly sightseeing.
Read the guideMedical aesthetics in China
Toxin, fillers, lasers and eyelid surgery — and how to check a clinic.
Read the guideSources
References
- van Zuuren EJ, Fedorowicz Z, Schoones J. Interventions for female pattern hair loss. Cochrane Database Syst Rev. 2016;(5):CD007628.
- Bergfeld W, et al. A phase III, multicenter, parallel-design clinical trial to compare the efficacy and safety of 5% minoxidil foam versus vehicle in women with female pattern hair loss. J Drugs Dermatol. 2016;15(7):874–881.
- Aleissa M. The efficacy and safety of oral spironolactone in the treatment of female pattern hair loss: a systematic review and meta-analysis. Cureus. 2023;15(8):e43559.
- Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977;97(3):247–254.
- Jimenez JJ, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15(2):115–127.
- PROPECIA (finasteride) tablets — US prescribing information (Organon, NDA 020788), DailyMed.
- International Society of Hair Restoration Surgery. 2025 Practice Census Results (2024 data; 247 member respondents).
- Wang TL, et al. Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol. 2010;162(4):843–847.
- True RH. Is every patient of hair loss a candidate for hair transplant? — Deciding surgical candidacy in pattern hair loss. Indian J Plast Surg. 2021;54(4):435–440.
Start with a proper
diagnosis.
We arrange a dermatology consultation at a public hospital in China, with interpreting, tests if needed, and a written plan in English you can continue at home.
This page is for general education only and is not medical advice. Whether a hair transplant or a medicine suits you depends on the cause and pattern of your hair loss, your donor area, your age and your health, and only a doctor who examines you can decide. Trial results describe groups of people, not what will happen to you. We are an independent patient-coordination service; we are not affiliated with any clinic chain or drug manufacturer and do not publish graft prices.
Published 7 November 2026 · Figures checked against the cited sources by the PandaTouring Care editorial team · Editorial policy